A recent systematic review published in the Journal of American Medical Association revealed that stricter opioid prescribing ...

The blood-brain barrier (BBB) is a major hurdle for the development of systemically delivered drugs targeting diseases of the ...

This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ... A New Discovery About Pain Signaling May Contribute to Better Treatment of Chronic Pain Nov. 18 ...

The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.

Tonix Pharmaceuticals Holding Corp. recently revealed in an 8-K filing with the U.S. Securities and Exchange Commission that the U.S. Food and Drug Administration (FDA) has set a Prescription Drug ...

Tonix Pharmaceuticals (NASDAQ: TNXP) announced that the FDA has set a Prescription Drug User Fee Act (“PDUFA”) goal date of Aug. 15, 2025, for a de ...

Tonix Pharmaceuticals (TNXP) said it has received a target action data of Aug. 15, 2025, for the application of its ...

Tonix Pharmaceuticals (TNXP) announced that the U.S. Food and Drug Administration, FDA, assigned a Prescription Drug User Fee Act, PDUFA, goal ...

He’s one of the lucky ones. In Chicago and other U.S. cities, Black men in Stewart’s generation, born from 1951 through 1970, have been dying of opioid poisoning at a greater rate than any ...

When you have fibromyalgia (FMS) or chronic fatigue syndrome (CFS or ME/CFS), it's common for well-meaning people to say things like, "If you'd just exercise more, you'd feel better." Research points ...

Those prescriptions included "dangerous and excessive quantities of opioids" and "trinity cocktails" — a blend of "especially dangerous and abused combination of drugs made up of an opioid ...

The global opioid use disorder treatment market is poised for significant growth, with an expected market size of USD 3.07 ...